Background: Pritchard regime is considered the benchmark for control of convulsions in patients with eclampsia. Indian patients with smaller body mass may require smaller doses of Magnesium sulfate.
INTRODUCTION
Eclampsia is a serious complication of pregnancy that affects the safety of the mother as well as the fetus. Until recently the treatment of eclampsia was diverse throughout the world. Various drugs and regimens have been advocated for the management of eclampsia. In 1950, Menon introduced the famous 'lytic cocktail' in India. 1 The lytic cocktail was a combination of drugs like pethidine, promethazine, and chlorpromazine. This lytic cocktail was only partially effective. Dr Prichard in 1984 used MgSO 4 for control of convulsions in eclamptic patients. This regimen was found to be very effective and became standard treatment for eclampsia. Indian women have lower body mass as compared to their western counterparts. Therefore, appropriate doses of magnesium sulfate and the therapeutic serum magnesium levels among the Indian patients have been a matter of debate. 2 This study was carried out to find out whether lower doses of MgSO 4 are as effective as standard doses for treatment of eclampsia in Indian patients.
AIM AND OBJECTIVES
To compare the effectiveness of low dose magnesium sulfate regimen in eclampsia and severe preeclampsia with standard Pritchard's regimen in terms of:
• Effectiveness in control of convulsions, • Maternal outcome • Magnesium related toxicity
MATERIALS AND METHODS

Study Area
Department of Obstetrics and Gynecology at the MGM Hospital, Kalamboli, Mumbai, Maharashtra, India.
Study Population
Pregnant patients above 20 weeks presenting with eclampsia at our hospital.
Study Design
A randomized comparative study
Sample Size Calculation
A total of 60 cases presenting with eclampsia at our hospital were randomly divided into two groups (30 each) using computer-generated random numbers: Group A: Standard Pritchard's regime. 
ORIGINAL ARTICLE MGMJMS
Methodology
Informed consent was taken from all the patients or their relatives (in case the patient was not in a condition to give consent). A detailed history was taken with special emphasis on the history of epilepsy or renal failure. Clinical assessment was carried out. Prepregnancy BMI was obtained from her old records. Following investigations were carried out: blood group, complete blood count (CBC), platelet count, serum creatinine, liver function tests, prothrombin time and urine analysis. Additional investigations were performed on the case to case basis.
Drug (MgSO 4 ) Regimen for Group A
• 4 g MgSO 4 20% IV stat.
• 3 g IM in each buttock stat.
• 2 g IM on alternate buttock four hourly for 24 hours after delivery or last convulsion whichever was later.
Drug (MgSO 4 ) Regimen for Group B
• 5 g on each buttock.
• 5 g IM 4 hourly on the alternate buttock. Medication was continued for 24 hours after the delivery or last seizure.
Respiratory rate, patellar reflexes and urinary output were monitored hourly for impending magnesium toxicity. Next scheduled dose of MgSO 4 was not given if there was any sign of magnesium toxicity (absence of patellar reflex, urinary output less than 30 mL/hour or respiratory rate less than 16/min). If convulsions recurred after the initial dose, the patient was given additional of 2 g of MgSO 4 by IV route. This additional dose of MgSO 4 was given to the patients in both groups. In case the patient had convulsions even after an additional dose of MgSO 4 , IV diazepam was given. Intravenous Labetalol in incremental doses of 20-80 mg was used if BP was more than 160/110. Lower segment cesserian section (LSCS)/ induction of labor was done to terminate the pregnancy within 48 hours of an initial dose of MgSO 4 .
Statistical Analysis
The quantitative data are represented as their mean ± SD. Categorical and nominal data is expressed in percentage. The t-test is used for analyzing quantitative data, or else nonparametric data are analyzed by Mann-Whitney test and categorical data are analyzed by using Chi-square test. The significance threshold of p value is set at < 0.05. All analyses were carried out by using Statistical Package for Social Sciences (SPSS) software version 21.
RESULTS
Mean age of patients in the study was 27.3 years with the majority of them (73.3%) between 21-30 years of age. No difference was observed among study groups with respect to age distribution (p 1.0). Out of the total 60 cases, 58.3% were primipara while the remaining 41.7% were multipara. No difference was observed among study groups with respect to parity (p 1.0). No difference was observed among study groups with respect to mean BMI and gestation age (p > 0.05), (Table 1) .
Out of the total 60 cases, 25% had more than five episodes of convulsions. No difference was observed among study groups with respect to a number of convulsion episodes (p 1.0). Overall success rate observed was 100% with a low dose regimen as compared to 93.3% with Pritchard's regimen. Additional doses were required in 2 cases of each group. Failure to control convulsions was noted in 2 cases of Pritchard's regimen group and none in the low dose regimen group ( Table 2) . The higher mean dose of MgSO 4 was associated with Pritchard's regimen (33.8 g) as compared to the low dose Low dose regimen (21.7 g) (p <0.01) ( Table 3 ).
Higher prevalence of cesarean section was observed in both groups (overall 61.7%). No difference was observed among study groups with respect to the type of delivery (p 0.59). Complications associated with magnesium, i.e., loss of knee jerk (30% vs. 6.7%) and oliguria (16.7% vs. 10%) were higher in cases with Pritchard's regimen (Table 4) .
DISCUSSION
Eclampsia is a major cause of maternal and fetal morbidity and mortality around the world, especially so in a developing country like India. Magnesium sulfate is the drug of choice for the treatment of eclampsia. The effectiveness of magnesium sulfate has been proven in a variety of randomized controlled trials. There has been a constant debate concerning the dose of magnesium sulfate . 2 Pritchard's regime has been tailored at different hospitals offering different regimes. Long-term statistical data has not been reported, and the protocol has not been standardized. Pritchard himself in 1984 suggested that the dose of magnesium sulfate should be limited in women who appear to be small built. 2 The present study was thus planned to compare the effectiveness of low dose magnesium sulfate regime with Pritchard's regime in controlling convulsions during eclampsia in Indian women.
Baseline Characteristics
Mean age of the females in the study was 27. 15 observed that 70% of women had a body weight less than 50 kilograms at the time of admission. Eclampsia occurs mostly in primigravida as seen in the study (59 %). Others have observed similar incidence: Ranjana et al. 10 70 %, Bangal et al. 15 15 75% and Sardesai et al. 16 79%.
CONTROL OF CONVULSIONS
A number of seizures occurring after the initial dose of MgSO 4 was the parameter used to measure the effectiveness of the drug. Recurrence of convulsions occurred in two patients in each group after the initial dose. These patients were given an additional dose of MgSO 4 . In group A, both the patients responded while in group B, in spite of giving 2 g i.v dose of MgSO 4 , further convulsions occurred in both the patients. The failure rate was 6.7% in Pritchard's regimen as compared to 0% in the low dose regimen (Table 2) . was reported. Ranjana et al., 10 Kumar et al., 13 Nautiyal et al. 11 and Mohanapu et al. 17 reported recurrence rate of 5%, 0.81%, 6.6%, and 10%, respectively with low dose regimen. All these results indicate that a low dose regime is as effective as the standard regime in controlling eclamptic seizures in Indian patients are in conformity to our study also. Higher prevalence of cesarean section was observed in both groups (overall 61.7%). No difference was observed among study groups with respect to the type of delivery (p 0.59). Most cesarean sections were carried out for fetal distress and nonprogress of labor (Table 4) . Cesarean section rate noted by Ranjana et al. 10 was 57.5% in Low Dose regimen and 67.5% in Pritchard's regimen. Nautiyal et al. 11 reported a cesarean section rate of 63% and Ali et al. 19 57.5 %. The high rate of LSCS in eclamptic mothers
as seen in most studies shows that obstetricians prefer elective LSCS to avoid complications likely to occur in mother and fetus while awaiting delivery. Institutional policies and protocols also have an influence on decisionmaking, whether to go for LSCS or vaginal delivery in patients with eclampsia.
MATERNAL COMPLICATIONS
A higher dose of MgSO 4 was used in Pritchard's regimen (mean 33.8 g) as compared to the low dose regimen (mean 21.7 g) ( Maternal mortality in cases of eclampsia ranges from 0.4% to 14%. Greater the organ damage and longer the delay in seeking treatment, higher is the mortality. In the present study, no mortality was observed because patients with serious complications of eclampsia were excluded.
A study conducted by Ranjana et al., 10 one mortality was reported in a low dose group and two in Pritchard's regimen (combined mortality rate of 3.75%). Sardesai et al. 16 reported a maternal mortality of 2.63%. The maternal mortality was 3% with a Pritchard regime group in the Collaborative eclampsia trial. 2 and study by Nautiyal et al. 11 reported a maternal mortality rate of 3.3%.
CONCLUSION
With this study, we came to a conclusion that a lower dose of magnesium sulfate is effective in controlling convulsions in eclampsia and has lesser complications compared to standard Pritchard's regimen in Indian patients, probably because of their less body mass. Further studies need to be conducted to re-evaluate the correct dosage of magnesium sulfate for the treatment of Indian patients with eclampsia. After all, why should we use higher doses of drugs if lesser doses are as effective and less toxic?
